Top

Gepubliceerd in:

2021 | OriginalPaper | Hoofdstuk

7. Preventie oedeem

Auteurs : Nele Devoogdt, PhD, PT, Robert Damstra, PhD, MD, Annemarieke Fleming, PhD, Sarah Thomis, MSc, MD, Sjan Lavrijsen, PhD, MD

Gepubliceerd in: Oedeem en oedeemtherapie

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

In dit hoofdstuk wordt dieper ingegaan op secundaire preventie, met name preventie van oedeem na kanker en bij personen met afwijkingen van het veneus stelsel. Omdat het niet gemakkelijk is om preventieve maatregelen vol te houden, wordt eerst ingegaan op de factoren die het naleven van preventieve strategieën positief of negatief kunnen beïnvloeden. Vervolgens wordt de epidemiologie, risicofactoren en de detectie van arm/been-oedeem besproken. Daarna wordt – gebaseerd op wetenschappelijk bewijs – een duidelijk overzicht gegeven van de verschillende preventieve maatregelen die patiënten met risico op arm/been-oedeem dienen te nemen. Tot slot wordt besproken welke wetenschappelijk onderbouwde behandelingen bij de patiënt met risico op oedeem uitgevoerd dienen te worden. Wilt u weten wat de rol is van het informeren van de patiënt, het uitvoeren van oefeningen, manuele lymfedrainage en compressietherapie in de preventie van oedeem, dan dient u dit hoofdstuk zeker te lezen.

vorige hoofdstuk Bijzondere groepen

Sherman KA, Koelmeyer L. Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer. Psychooncology. 2013;22(5):1120–6. https://doi.org/10.1002/pon.3111 [published Online First: 2012/06/13].

McLaughlin SA, Bagaria S, Gibson T, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. J Am Coll Surg. 2013;216(3):380–9; quiz 511–3. https://doi.org/10.1016/j.jamcollsurg.2012.11.004 [published Online First: 2012/12/26].

Radina ME, Armer JM, Stewart BR. Making self-care a priority for women at risk of breast cancer-related lymphedema. J Fam Nurs. 2014;20(2):226–49. https://doi.org/10.1177/1074840714520716 [published Online First: 2014/01/31].

Radina E, Armer J, Daunt D, et al. Self-reported management of breast cancer-related lymphoedema. J Lymphoedema. 2007;2(2):12–21.PubMedPubMedCentral

Fu MR. Cancer survivors’ views of lymphoedema management. J Lymphoedema. 2010;5(2):39–48 [published Online First: 2010/01/01].

Arnsten AF. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009;10(6):410–22. https://doi.org/10.1038/nrn2648 [published Online First: 2009/05/21].

Trappenburg J, Jonkman N, Jaarsma T, et al. Zelfmanagement bij chronische ziekten. Huisarts & Wetenschap. 2014;57(3):120–4.

DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15. https://doi.org/10.1016/S1470-2045(13)70076-7.CrossRefPubMed

Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98(5):343–8. https://doi.org/10.1093/qjmed/hci053 [published Online First: 2005/04/12].

10.

Ancukiewicz M, Miller CL, Skolny MN, et al. Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology. Breast Cancer Res Treat. 2012;135(1):145–52. https://doi.org/10.1007/s10549-012-2111-8 [published Online First: 2012/06/20].

11.

Gebruers N, Verbelen H, De Vrieze T, et al. Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: a best practice guideline. Eur J Obstet Gynecol Reprod Biol. 2017. https://doi.org/10.1016/j.ejogrb.2017.07.035 [published Online First: 2017/08/16].

12.

Gebruers N, Truijen S, Engelborghs S, et al. Volumetric evaluation of upper extremities in 250 healthy persons. Clin Physiol Funct Imaging. 2007;27(1):17–22. https://doi.org/10.1111/j.1475-097x.2007.00708.x [published Online First: 2007/01/06].

13.

Hidding JT, Beurskens CHG, De Vries MT, et al. Accuracy of a single measurement site for self-monitoring of patients with breast cancer at risk for lymphedema. Physiother Theory Pract. 2018:1–6. https://doi.org/10.1080/09593985.2018.1474404 [published Online First: 2018/05/15].

14.

Verbelen H, Gebruers N, Beyers T, et al. Breast edema in breast cancer patients following breast-conserving surgery and radiotherapy: a systematic review. Breast Cancer Res Treat. 2014;147(3):463–71. https://doi.org/10.1007/s10549-014-3110-8.CrossRefPubMed

15.

Verbelen H, De Vrieze T, Van Soom T, et al. Development and clinimetric properties of the Dutch Breast Edema Questionnaire (BrEQ-Dutch version) to diagnose the presence of breast edema in breast cancer patients. Qual Life Res. 2019; Accepted.

16.

Stout Gergich NL, Pfalzer LA, McGarvey C, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19. https://doi.org/10.1002/cncr.23494 [published Online First: 2008/04/23].

17.

Specht MC, Miller CL, Russell TA, et al. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat. 2013;140(3):485–94. https://doi.org/10.1007/s10549-013-2655-2 [published Online First: 2013/08/06].

18.

Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16(7):1959–72. https://doi.org/10.1245/s10434-009-0452-2 [published Online First: 2009/04/15].

19.

Paskett ED, Dean JA, Oliveri JM, et al. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30(30):3726–33. https://doi.org/10.1200/jco.2012.41.8574 [published Online First: 2012/09/26].

20.

Ahn S, Port ER. Lymphedema precautions: time to abandon old practices? J Clin Oncol. 2016;34(7):655–8. https://doi.org/10.1200/JCO.2015.64.9574.CrossRefPubMed

21.

Cemal Y, Pusic A, Mehrara BJ. Preventative measures for lymphedema: separating fact from fiction. J Am Coll Surg. 2011;213(4):543–51. https://doi.org/10.1016/j.jamcollsurg.2011.07.001 [published Online First: 2011/08/02].

22.

Bryant JR, Hajjar RT, Lumley C, et al. Clinical Inquiry-In women who have undergone breast cancer surgery, including lymph node removal, do blood pressure measurements taken in the ipsilateral arm increase the risk of lymphedema? J Okla State Med Assoc. 2016;109(11):529–31 [published Online First: 2017/01/28].

23.

Ferguson CM, Swaroop MN, Horick N, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34(7):691–8. https://doi.org/10.1200/jco.2015.61.5948 [published Online First: 2015/12/09].

24.

Kilbreath SL, Ward LC, Lane K, et al. Effect of air travel on lymphedema risk in women with history of breast cancer. Breast Cancer Res Tr. 2010;120(3):649–54. https://doi.org/10.1007/s10549-010-0793-3 [published Online First: 2010/02/25].

25.

Showalter SL, Brown JC, Cheville AL, et al. Lifestyle risk factors associated with arm swelling among women with breast cancer. Ann Surg Oncol. 2013;20(3):842–9. https://doi.org/10.1245/s10434-012-2631-9 [published Online First: 2012/10/12].

26.

Box RC, Reul-Hirche HM, Bullock-Saxton JE, et al. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat. 2002;75(1):51–64 [published Online First: 2002/12/26].

27.

Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304(24):2699–705. https://doi.org/10.1001/jama.2010.1837 [published Online First: 2010/12/15].

28.

Lacomba MT, Sanchez MJY, Goni AZ, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396. https://doi.org/10.1136/bmj.b5396.CrossRef

29.

Devoogdt N, Geraerts I, Van Kampen M, et al. Manual lymph drainage may not have a preventive effect on the development of breast cancer-related lymphoedema in the long term: a randomised trial. J Physiother. 2018;64(4):245–54. https://doi.org/10.1016/j.jphys.2018.08.007 [published Online First: 2018/09/23].

30.

Zimmermann A, Wozniewski M, Szklarska A, et al. Efficacy of manual lymphatic drainage in preventing secondary lymphedema after breast cancer surgery. Lymphology. 2012;45:103–12.PubMed

31.

Ochalek K, Gradalski T, Partsch H. Preventing early postoperative arm swelling and lymphedema manifestation by compression sleeves after axillary lymph node interventions in breast cancer patients: a randomized controlled trial. J Pain Symptom Manage. 2017;54(3):346–54. https://doi.org/10.1016/j.jpainsymman.2017.04.014 [published Online First: 2017/08/12].

32.

Lane KN, Dolan LB, Worsley D, et al. Upper extremity lymphatic function at rest and during exercise in breast cancer survivors with and without lymphedema compared with healthy controls. J Appl Physiol. 2007;103(3):917–25. https://doi.org/10.1152/japplphysiol.00077.2007 [published Online First: 2007/06/23].

33.

Devoogdt N, Christiaens MR, Geraerts I, et al. Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trial. BMJ. 2011;343:d5326 [published Online First: 2011/09/03].

34.

Damstra RJ, Kaandorp CJ. Dutch Institute for Health Care Improvement (CBO) Guideline ‘Lymphedema’. Ned Tijdschr Geneeskd. 2003;147(14):648–52 [published Online First: 2003/04/26].

35.

De Groef A, Van Kampen M, Dieltjens E, et al. Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil. 2015;96(6):1140–53. https://doi.org/10.1016/j.apmr.2015.01.006.CrossRefPubMed

36.

Juvet LK, Thune I, Elvsaas I, et al. The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: a meta-analysis. Breast. 2017;33:166–77. https://doi.org/10.1016/j.breast.2017.04.003 [published Online First: 2017/04/18].

37.

Cormier JN, Askew RL, Mungovan KS, et al. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010;116(22):5138–49. https://doi.org/10.1002/cncr.25458 [published Online First: 2010/07/29].

38.

Yoshihara M, Shimono R, Tsuru S, et al. Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: a multi-institutional retrospective study. Eur J Surg Oncol. 2020. https://doi.org/10.1016/j.ejso.2020.01.033 [published Online First: 2020/03/09].

39.

Kim JH, Choi JH, Ki EY, et al. Incidence and risk factors of lower-extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer. Int J Gynecol Cancer. 2012;22(4):686–91. https://doi.org/10.1097/IGC.0b013e3182466950.CrossRefPubMed

40.

Ohba Y, Todo Y, Kobayashi N, et al. Risk factors for lower-limb lymphedema after surgery for cervical cancer. Int J Clin Oncol. 2011;16(3):238–43. https://doi.org/10.1007/s10147-010-0171-5 [published Online First: 2011/01/08].

41.

Schneidman HM. Treatment of circulatory disorders of the lower extremities. Calif Med. 1966;105(5):368–70 [published Online First: 1966/11/01].

42.

Simon DA, Dix FP, McCollum CN. Management of venous leg ulcers. BMJ. 2004;328(7452):1358–62. https://doi.org/10.1136/bmj.328.7452.1358 [published Online First: 2004/06/05].

43.

Abu-Own A, Scurr JH, Coleridge Smith PD. Effect of leg elevation on the skin microcirculation in chronic venous insufficiency. J Vasc Surg. 1994;20(5):705–10. https://doi.org/10.1016/s0741-5214(94)70157-1 [published Online First: 1994/11/01].

44.

Dix FP, Reilly B, David MC, et al. Effect of leg elevation on healing, venous velocity and ambulatory venous pressure in venous ulceration. Phlebology 2005;20(2):87–94.

45.

Bourne IH. Vertical leg drainage of odema in treatment of leg ulcers. Br Med J. 1974;2(5919):581–3. https://doi.org/10.1136/bmj.2.5919.581 [published Online First: 1974/06/15].

46.

Fergusson AG, Logan JC. Leg ulcers: assessment of response to certain topical medicaments. Br Med J. 1961;1(5229):871–4. https://doi.org/10.1136/bmj.1.5229.871 [published Online First: 1961/03/25].

47.

Vuylsteke ME, Colman R, Thomis S, et al. An epidemiological survey of venous disease among general practitioner attendees in different geographical regions on the globe: the final results of the vein consult program. Angiology. 2018;69(9):779–85. https://doi.org/10.1177/0003319718759834 [published Online First: 2018/02/28].

48.

Kostas TI, Ioannou CV, Drygiannakis I, et al. Chronic venous disease progression and modification of predisposing factors. J Vasc Surg. 2010;51(4):900–7. https://doi.org/10.1016/j.jvs.2009.10.119 [published Online First: 2010/03/30].

49.

Rabe E, Partsch H, Hafner J, et al. Indications for medical compression stockings in venous and lymphatic disorders: an evidence-based consensus statement. Phlebology. 2018;33(3):163–84. https://doi.org/10.1177/0268355516689631 [published Online First: 2017/05/28].

50.

Clarke MJ, Broderick C, Hopewell S, et al. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database Syst Rev. 2016;9:CD004002. https://doi.org/10.1002/14651858.cd004002.pub3 [published Online First: 2016/09/15].

51.

Ochalek K, Pacyga K, Curylo M, et al. Risk factors related to lower limb edema, compression, and physical activity during pregnancy: a retrospective study. Lymphat Res Biol. 2017;15(2):166–71. https://doi.org/10.1089/lrb.2016.0038 [published Online First: 2017/03/28].

52.

Stuiver MM, De Rooij JD, Lucas C, et al. No evidence of benefit from class-II compression stockings in the prevention of lower-limb lymphedema after inguinal lymph node dissection: results of a randomized controlled trial. Lymphology. 2013;46(3):120–31.PubMed

53.

Sawan S, Mugnai R, Lopes Ade B, et al. Lower-limb lymphedema and vulval cancer: feasibility of prophylactic compression garments and validation of leg volume measurement. Int J Gynecol Cancer. 2009;19(9):1649–54. https://doi.org/10.1111/igc.0b013e3181a8446a [published Online First: 2009/12/04].

54.

Hnin YK, Ong LX, Tsai CC, et al. Does initial routine use of a compression garment reduce the risk of lower limb lymphedema after gynecological cancer treatment? A randomized pilot study in an Asian institution and review of the literature. Lymphology. 2018;51(4):174–83 [published Online First: 2018/01/01].

55.

Lane K, Worsley D, McKenzie D. Exercise and the lymphatic system: implications for breast-cancer survivors. Sports Med. 2005;35(6):461–71. https://doi.org/10.2165/00007256-200535060-00001 [published Online First: 2005/06/25].

56.

Brunner U, Fleishlin C. Enstauungsgymnastik. VASA. 1992;21:206–9.PubMed

57.

Padberg FT, Jr., Johnston MV, Sisto SA. Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomized trial. J Vasc Surg. 2004;39(1):79–87. https://doi.org/10.1016/j.jvs.2003.09.036 [published Online First: 2004/01/14].

58.

Boccardo F, De Cian F, Campisi CC, et al. Surgical prevention and treatment of lymphedema after lymph node dissection in patients with cutaneous melanoma. Lymphology. 2013;46(1):20–6 [published Online First: 2013/08/13].

59.

Morotti M, Menada MV, Boccardo F, et al. Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer. Int J Gynecol Cancer. 2013;23(4):769–74. https://doi.org/10.1097/igc.0b013e318287a8e8 [published Online First: 2013/03/15].

60.

Stoberl C, Partsch H. Erysipelas and lymphedema–egg or hen? Z Hautkr. 1987;62(1):56–62 [published Online First: 1987/01/01].

61.

Damstra RJ, Van Steensel MA, Boomsma JH, et al. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol. 2008;158(6):1210–5. https://doi.org/10.1111/j.1365-2133.2008.08503.x [published Online First: 2008/03/28].

62.

Lavrijsen APM, Damstra RJ, Van Dissel JT, et al. Richtlijn cellulitis en erysipelas van de onderste extremiteiten. 2013 [Available from: https://www.alii.care//engine/download/blob/alii/470/2019/41/20190717_richtlijn-erysipelas-en-cellulitis-definitief.pdf?app=alii&class=74&id=2159&field=470 [last accessed 22–1-2019]].

63.

Brodell LA, Brodell JD, Brodell RT. Recurrent lymphangitic cellulitis syndrome: a quintessential example of an immunocompromised district. Clin Dermatol. 2014;32(5):621–7. https://doi.org/10.1016/j.clindermatol.2014.04.009 [published Online First: 2014/08/28].

64.

De Godoy JM, De Godoy MF, Valente A, et al. Lymphoscintigraphic evaluation in patients after erysipelas. Lymphology. 2000;33(4):177–80 [published Online First: 2001/02/24].

Titel: Preventie oedeem
Auteurs: Nele Devoogdt, PhD, PT
Robert Damstra, PhD, MD
Annemarieke Fleming, PhD
Sarah Thomis, MSc, MD
Sjan Lavrijsen, PhD, MD
Uitgeverij: Bohn Stafleu van Loghum
Boek: Oedeem en oedeemtherapie
Print ISBN: 978-90-368-2589-4

Elektronisch ISBN: 978-90-368-2590-0

Copyright: 2021
DOI: https://doi.org/10.1007/978-90-368-2590-0_7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen